Masato Horikawa
- Pharmacology top 2%
- Microbiology top 5%
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 6
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
-
- Organ Transplantation Techniques and Outcomes 6
- Tissue Engineering and Regenerative Medicine 3
-
- RNA Interference and Gene Delivery 5
-
- 3D Printing in Biomedical Research 4
-
- Liver physiology and pathology 3
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Yuichi SugiyamaYukio KatoCharles A. TysonMotohiro KatoKōji ChibaPing HuMichael F. BarileWallace A. Clyde
- Cited by
- PharmacologyMicrobiologyOncology
- Partner nations
- JapanUnited StatesPuerto Rico
In The Last Decade
Masato Horikawa
37 papers receiving 573 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 188
- Microbiology 72
- Oncology 281
- Transplantation 19
- Pediatrics, Perinatology and Child Health 123
Countries citing papers authored by Masato Horikawa
This map shows the geographic impact of Masato Horikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Horikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Horikawa more than expected).
Fields of papers citing papers by Masato Horikawa
This network shows the impact of papers produced by Masato Horikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Horikawa. The network helps show where Masato Horikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masato Horikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 13 | |
| 5 | 2016 | 1 | |
| 6 | 2014 | 21 | |
| 7 | 2011 | 21 | |
| 8 | 2006 | 0 | |
| 9 | 2004 | 4 | |
| 10 | 2003 | 52 | |
| 11 | 2002 | 69 | |
| 12 | 2002 | 88 | |
| 13 | 2000 | 1 | |
| 14 | 1998 | 3 | |
| 15 | 1997 | 2 | |
| 16 | 1994 | 3 | |
| 17 | Warm ischemic pancreas as potential graft for islet transplantation. | 1994 | 1 |
| 18 | 1993 | 14 | |
| 19 | 1992 | 1 | |
| 20 | 1991 | 1 |
About Masato Horikawa
Masato Horikawa is a scholar working on Transplantation, Hepatology and Surgery, having authored 41 papers that have together received 601 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (6 papers), Drug Transport and Resistance Mechanisms (6 papers), RNA Interference and Gene Delivery (5 papers), 3D Printing in Biomedical Research (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Tissue Engineering and Regenerative Medicine (3 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Pharmacology (188 citations), Microbiology (72 citations) and Oncology (281 citations). Masato Horikawa has collaborated with scholars based in Japan, United States and Puerto Rico. Frequent co-authors include Yuichi Sugiyama, Yukio Kato, Charles A. Tyson, Motohiro Kato, Kōji Chiba, Ping Hu, Michael F. Barile, Wallace A. Clyde, Albert M. Collier and Yen‐Sung Huang. Their work appears in journals such as Biomaterials, Infection and Immunity and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.